Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,125 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 450 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Mar 6, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 |
| clinicaltrials |
| NCT00101660 | Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib | completed | Phase 2 | 387 | Bristol-Myers SquibbINDUSTRY | 22 | Mar 2, 2012 | clinicaltrials |
| NCT00936442 | Arimidex Therapy Compliance Electronic Monitoring System(ARTEMIS) | completed | — | 104 | AstraZenecaINDUSTRY | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT00714025 | A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy | completed | Phase 2 | 40 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jan 24, 2012 | clinicaltrials |
| NCT00003212 | Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 3 | 780 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Jan 20, 2012 | clinicaltrials |
| NCT01513109 | Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia(ASCI) | unknown | Phase 1 / Phase 2 | 20 | Jules Bordet InstituteOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00067314 | Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy | completed | Phase 2 | 65 | PfizerINDUSTRY | 4 | Jan 18, 2012 | clinicaltrials |
| NCT01260038 | Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.(HERMES) | completed | — | 107 | University Hospital, AntwerpOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT00048230 | PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | completed | Phase 3 | 620 | Millennium Pharmaceuticals, Inc.INDUSTRY | 13 | Jan 13, 2012 | clinicaltrials |
| NCT00063726 | A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 | completed | Phase 3 | 600 | Millennium Pharmaceuticals, Inc.INDUSTRY | 13 | Jan 13, 2012 | clinicaltrials |
| NCT00448305 | EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients | completed | Phase 2 | 143 | MediGeneINDUSTRY | 6 | Jan 5, 2012 | clinicaltrials |
| NCT00677859 | Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia | completed | Phase 1 | 36 | Healios K.K.INDUSTRY | 2 | Jan 5, 2012 | clinicaltrials |
| NCT00401401 | Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 30 | GenmabINDUSTRY | 5 | Dec 23, 2011 | clinicaltrials |
| NCT01063946 | A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor | completed | Phase 1 | 3 | SanofiINDUSTRY | 1 | Dec 21, 2011 | clinicaltrials |
| NCT01087021 | Effect of Cabazitaxel on the QTc Interval in Cancer Patients(QT-Cab) | completed | Phase 1 | 45 | SanofiINDUSTRY | 5 | Dec 16, 2011 | clinicaltrials |
| NCT00460551 | Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer | terminated | Phase 2 | 13 | GenmabINDUSTRY | 5 | Dec 6, 2011 | clinicaltrials |
| NCT00820508 | Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies(CHR-2845-001) | completed | Phase 1 | 18 | Chroma TherapeuticsINDUSTRY | 3 | Nov 28, 2011 | clinicaltrials |
| NCT00418574 | Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients(MIMOSA) | terminated | Phase 2 / Phase 3 | 888 | Menarini GroupINDUSTRY | 9 | Nov 24, 2011 | clinicaltrials |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 21 | Nov 16, 2011 | clinicaltrials |
| NCT00174655 | BIG 02/98 Docetaxel - Breast Cancer | completed | Phase 3 | 2,887 | SanofiINDUSTRY | 21 | Nov 10, 2011 | clinicaltrials |
| NCT00519090 | Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)(ENEST) | terminated | Phase 3 | 6 | Novartis PharmaceuticalsINDUSTRY | 10 | Nov 7, 2011 | clinicaltrials |
| NCT01466010 | Treatment Outcome After Surgical Treatment of Osteoid Osteoma | completed | — | 150 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Nov 7, 2011 | clinicaltrials |
| NCT01340989 | CO2 Absorption During Laparoscopy | completed | N/A | 60 | University Hospital, GasthuisbergOTHER | 1 | Oct 26, 2011 | clinicaltrials |
| NCT01332240 | External ValidatIon Trial of ASTER Trial(EVITA) | unknown | N/A | 255 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Oct 19, 2011 | clinicaltrials |
| NCT00722566 | A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma | completed | Phase 3 | 222 | Millennium Pharmaceuticals, Inc.INDUSTRY | 3 | Oct 10, 2011 | clinicaltrials |
| NCT01225003 | Advanced MR Techniques in Detection of Tumor Infiltration and Grading in Gliomas | completed | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Sep 29, 2011 | clinicaltrials |
| NCT01318785 | Therapeutical Assessment of Compression Armsleeves for Lymphatic Indications(BF09-PH-01) | unknown | Phase 2 | 40 | University Medicine GreifswaldOTHER | 4 | Sep 7, 2011 | clinicaltrials |
| NCT00504803 | Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease | completed | Phase 2 | 30 | University of LiegeOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00693927 | Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC) | completed | Phase 2 | 54 | University of LiegeOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00297648 | Mucosal Healing Study in Crohn's Disease (CD)(MUSIC) | completed | Phase 3 | 89 | UCB PharmaINDUSTRY | 3 | Aug 31, 2011 | clinicaltrials |
| NCT00302016 | Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 34 | Aug 26, 2011 | clinicaltrials |
| NCT00655252 | Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 13 | Aug 19, 2011 | clinicaltrials |
| NCT00057720 | TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer | completed | Phase 3 | 440 | TelikINDUSTRY | 13 | Jul 25, 2011 | clinicaltrials |
| NCT00243503 | Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer | completed | Phase 2 | 60 | PfizerINDUSTRY | 5 | Jul 22, 2011 | clinicaltrials |
| NCT00634777 | Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma(pet) | unknown | N/A | 239 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT01056796 | Compression Anastomosis For Low Anterior Resection in Previously Radiated Patients Using the CAR™ 27 | unknown | Phase 2 | 10 | Niti Medical Technologies Ltd.INDUSTRY | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00497263 | End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study | completed | Phase 2 | — | Niti Medical Technologies Ltd.INDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00415194 | A Study for Patients With Head and Neck Cancer | completed | Phase 3 | 795 | Eli Lilly and CompanyINDUSTRY | 21 | Jun 28, 2011 | clinicaltrials |
| NCT00485979 | Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients(SATIN) | completed | Phase 2 | 330 | SanofiINDUSTRY | 8 | Jun 28, 2011 | clinicaltrials |
| NCT00994136 | Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters | completed | Phase 4 | 1,100 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jun 9, 2011 | clinicaltrials |
| NCT01077869 | A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis | terminated | — | 10 | University Hospital, GhentOTHER | 1 | May 26, 2011 | clinicaltrials |
| NCT00342056 | Role of Gene Variation in Effectiveness of Gleevec Treatment | completed | — | 100 | National Cancer Institute (NCI)NIH | 2 | May 25, 2011 | clinicaltrials |
| NCT00405210 | Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer | completed | Phase 1 | 38 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | May 23, 2011 | clinicaltrials |
| NCT00616135 | Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy(RESTORE-2) | completed | Phase 4 | 71 | Cytori TherapeuticsINDUSTRY | 4 | May 17, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT00559624 | Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients | completed | Phase 1 / Phase 2 | 40 | Advancell - Advanced In Vitro Cell Technologies, S.A.INDUSTRY | 3 | May 10, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials